Benzinga's Top #PreMarket Gainers
September 26, 2014 at 08:02 AM EDT
Repros Therapeutics (NASDAQ: RPRX) shares jumped 15.51% to $10.35 in pre-market trading following the announcement that Androxal ZA-304 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.